Canyam
AI summaries for academic research
Home
Literature Help
Subscribe
Favorites
Tools
Analysis
Summary
Patents
Not logged in
Back
J
Jerry Avorn
Department of Medicine
119
H-index
667
Paper Count
5.2W
Citation Count
0
Related Insights
Subscribe
Published Papers
343
Publication Date
Publication Date
Impact Factor
Citations
Communicating Drug Safety and Safe Use Conditions in Risk Evaluation and Mitigation Strategy Materials
Drug Safety
IF
3.8
2026-09-02
0
PRE
AI
Ameet Sarpatwari; Frazer A. Tessema; Mayookha Mitra-Majumdar; Su Been Lee; Heidi Zakoul; Beatrice L. Brown; Gita A. Toyserkani; Kate Heinrich Oswell; Cynthia LaCivita; Gerald J. Dal Pan; Steven Woloshin; Jerry Avorn; Aaron S. Kesselheim
Share
Save
Money, Meals, and Marketing in Medicine: A 13-Year Follow-Up Survey of Physicians
CLINICAL PHARMACOLOGY & THERAPEUTICS
IF
5.5
2026-08-11
0
PRE
AI
Helen Mooney; Kirsten Austad; Eric G. Campbell; Jerry Avorn; Zhigang Lu; Aaron S. Kesselheim
Share
Save
The 25th Anniversary of a Nearly Unknown Health Policy Turning Point
New England Journal of Medicine
IF
78.5
2025-12-01
0
PRE
AI
Avorn, Jerry
Share
Save
Comparative Bleeding Risk in Older Patients With HIV and Atrial Fibrillation Receiving Oral Anticoagulants
JAMA INTERNAL MEDICINE
IF
23.3
2025-02-24
0
PRE
AI
Quinlan, Claire M.; Avorn, Jerry; Kesselheim, Aaron S.; Singer, Daniel E.; Zhang, Yichi; Cervone, Alex
Share
Save
Invited commentary on interventional pharmacoepidemiology: origins, current status, and future possibilities
AMERICAN JOURNAL OF EPIDEMIOLOGY
IF
4.8
2024-10-10
2
PRE
AI
Avorn, Jerry
Share
Save
Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study
BMJ-BRITISH MEDICAL JOURNAL
IF
42.7
2024-08-20
0
OA
AI
Tibau, Ariadna; Hwang, Thomas J.; Avorn, Jerry; Kesselheim, Aaron S.
Share
Save
Clinical Value of Molecular Targets and Genome-Targeted Cancer Therapies Recommended by the National Comprehensive Cancer Network for Advanced Breast Cancer
CANCER RESEARCH
IF
16.6
2024-05-02
0
PRE
AI
Tibau, Ariadna; Hwang, Thomas J.; Avorn, Jerry; Kesselheim, Aaron
Share
Save
Value of Molecular Targets and Genome-Targeted Therapies FDA-Approved for Metastatic Breast Cancer, 2006-2023
CANCER RESEARCH
IF
16.6
2024-05-02
0
PRE
AI
Tibau, Ariadna; Hwang, Thomas J.; Valiente, Consolacion Molto; Avorn, Jerry; Kesselheim, Aaron
Share
Save
Use of Efficiency Frontiers to Align Prices and Clinical Benefits of Biologic Therapies for Plaque Psoriasis
JAMA DERMATOLOGY
IF
11
2024-04-01
3
PRE
AI
Egilman, Alexander C.; Kesselheim, Aaron S.; Avorn, Jerry; Raymakers, Adam J. N.; Rome, Benjamin N.
Share
Save
Pragmatic trial evaluating the impact of simulation training on high-risk prescribing to older adults by junior physicians
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
IF
4.5
2024-03-08
0
PRE
AI
Lauffenburger, Julie C.; DiFrancesco, Matthew F.; Bhatkhande, Gauri; Crum, Katherine L.; Kim, Erin; Robertson, Ted; Oran, Rebecca; Hanken, Kaitlin E.; Haff, Nancy; Coll, Maxwell D.; Avorn, Jerry; Choudhry, Niteesh K.
Share
Save
Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES
IF
6.7
2024-03-01
1
PRE
AI
Lin, Kueiyu Joshua; Singer, Daniel E.; Avorn, Jerry; Heist, E. Kevin; Sreedhara, Sushama Kattinakere; Anand, Priyanka; Zhang, Yichi; Tsacogianis, Theodore N.; Schneeweiss, Sebastian
Share
Save
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease In Response
ANNALS OF INTERNAL MEDICINE
IF
15.2
2024-01-01
0
PRE
AI
Feldman, William B.; Kesselheim, Aaron S.; Avorn, Jerry; Russo, Massimiliano; Wang, Shirley V.
Share
Save
Wedding Websites, Free Speech, and Adverse Drug Effects
NEW ENGLAND JOURNAL OF MEDICINE
IF
78.5
2023-10-19
0
PRE
AI
Avorn, Jerry
Share
Save
Value of molecular targets and genome-targeted cancer therapies FDA-approved, 2015-2022
ANNALS OF ONCOLOGY
IF
65.4
2023-10-01
0
OA
AI
Tibau, A.; Hwang, T. J.; Consolacion, M.; Avorn, J.; Kesselheim, A.
Share
Save
The Regulatory Repercussions of Approving Muscular Dystrophy Medications on the Basis of Limited Evidence
ANNALS OF INTERNAL MEDICINE
IF
15.2
2023-09-01
4
PRE
AI
Bendicksen, Liam; Zuckerman, Diana M.; Avorn, Jerry; Phillips, Sophia; Kesselheim, Aaron S.
Share
Save
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease
ANNALS OF INTERNAL MEDICINE
IF
15.2
2023-08-01
2
PRE
AI
Feldman, William B.; Kesselheim, Aaron S.; Avorn, Jerry; Russo, Massimiliano; Wang, Shirley V.
Share
Save
Federal Funding For Discovery And Development Of Costly HIV Drugs Was Far More Than Previously Estimated
HEALTH AFFAIRS
IF
8.1
2023-05-01
1
PRE
AI
Tessema, Frazer A.; Barenie, Rachel E.; Avorn, Jerry; Kesselheim, Aaron S.
Share
Save
US public investment in development of mRNA covid-19 vaccines: retrospective cohort study
BMJ-BRITISH MEDICAL JOURNAL
IF
42.7
2023-03-01
24
OA
AI
Lalani, Hussain S.; Nagar, Sarosh; Sarpatwari, Ameet; Barenie, Rachel E.; Avorn, Jerry; Rome, Benjamin N.; Kesselheim, Aaron S.
Share
Save
Sources of Innovation in Gene Therapies - Approaches to Achieving Affordable Prices
NEW ENGLAND JOURNAL OF MEDICINE
IF
78.5
2023-01-26
8
PRE
AI
Vokinger, Kerstin N.; Avorn, Jerry; Kesselheim, Aaron S.
Share
Save
Trends in the Quality of Evidence Supporting FDA Drug Approvals: Results from a Literature Review
JOURNAL OF HEALTH POLITICS POLICY AND LAW
IF
2.8
2022-07-14
7
OA
AI
Brown, Beatrice L.; Mitra-Majumdar, Mayookha; Joyce, Krysten; Ross, Murray; Pham, Catherine; Darrow, Jonathan J.; Avorn, Jerry; Kesselheim, Aaron S.
Share
Save
Research Directions
The data has not been retrieved yet.
Co-authors
Cooperation Journals
J
JoAnn E. Manson
H-index: 255 · Papers: 2.7K
E
Elliott M. Antman
H-index: 169 · Papers: 849
C
Charles H. Hennekens
H-index: 155 · Papers: 782
G
George Perry
H-index: 152 · Papers: 1.5K
M
Ming T. Tsuang
H-index: 148 · Papers: 1.3K
View more